Moderna Biotechnology Company received additional US $ 472 million in support from the US government to support the development of the company's new vaccine for coronavirus.
According to Reuters, the company stated that it had received the grant from the Biomedical Development and Research Authority, noting that the additional funding would support its advanced stage in its clinical trials, including This is a study of the extended third stage of a possible vaccine.
The federal government had supported a former vaccine project from our directorate with nearly half a billion dollars, and chose it as one of the first vaccines to engage in large-scale human trials.
(Amazon fun of knowledge)
